Thursday, 31 January 2019 05:53

Infant Ibuprofen Recall Expanded

A recall of infant ibuprofen has been expanded by Tris Pharma Incorporated, according to a report.

The New Jersey-based pharmaceutical company first recalled the infant ibuprofen drops back in November last year due to a higher concentration of ibuprofen in the drug than it was labeled, some doses as high as 10 percent above the advertised limit.

The affected medicine is Infants' Ibuprofen Oral Suspension Drops, USP, 50 milligrams per 1.25 milliliters.

See more at

Published in Local